These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7097123)

  • 41. Inhibition of the class II HMG-CoA reductase of Pseudomonas mevalonii.
    Hedl M; Rodwell VW
    Protein Sci; 2004 Jun; 13(6):1693-7. PubMed ID: 15152097
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of cholesterol synthesis in rat adrenal gland through coordinate control of 3-hydroxy-3-methylglutaryl coenzyme A synthase and reductase activities.
    Balasubramaniam S; Goldstein JL; Brown MS
    Proc Natl Acad Sci U S A; 1977 Apr; 74(4):1421-5. PubMed ID: 16260
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mevalonic acid-dependent degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in vivo and in vitro.
    Correll CC; Edwards PA
    J Biol Chem; 1994 Jan; 269(1):633-8. PubMed ID: 8276863
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo regulation of rat liver 3-hydroxy-3-methylglutaryl-coenzyme A reductase: enzyme phosphorylation as an early regulatory response after intragastric administration of mevalonolactone.
    Arebalo RE; Hardgrave JE; Noland BJ; Scallen TJ
    Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6429-33. PubMed ID: 6256737
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Geranylgeranyl-pyrophosphate, an isoprenoid of mevalonate cascade, is a critical compound for rat primary cultured cortical neurons to protect the cell death induced by 3-hydroxy-3-methylglutaryl-CoA reductase inhibition.
    Tanaka T; Tatsuno I; Uchida D; Moroo I; Morio H; Nakamura S; Noguchi Y; Yasuda T; Kitagawa M; Saito Y; Hirai A
    J Neurosci; 2000 Apr; 20(8):2852-9. PubMed ID: 10751437
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of mevalonate synthesis in low density lipoprotein receptor knockout mice fed n-3 or n-6 polyunsaturated fatty acids.
    El-Sohemy A; Archer MC
    Lipids; 1999 Oct; 34(10):1037-43. PubMed ID: 10580331
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of poloxamer 407 on the activity of microsomal 3-hydroxy-3-methylglutaryl CoA reductase in rats.
    Johnston TP; Palmer WK
    J Cardiovasc Pharmacol; 1997 May; 29(5):580-5. PubMed ID: 9213198
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Localization of 3-hydroxy-3-methylglutaryl CoA reductase and 3-hydroxy-3-methylglutaryl CoA synthase in the rat liver and intestine is affected by cholestyramine and mevinolin.
    Li AC; Tanaka RD; Callaway K; Fogelman AM; Edwards PA
    J Lipid Res; 1988 Jun; 29(6):781-96. PubMed ID: 2902179
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization and regulation of HMG-CoA reductase during a cycle of juvenile hormone synthesis.
    Feyereisen R; Farnsworth DE
    Mol Cell Endocrinol; 1987 Oct; 53(3):227-38. PubMed ID: 3666299
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of decreased plasma cholesterol concentration on circulatinga mevalonate metabolism in rats.
    Feingold KR; Wiley MH; MacRae G; Siperstein MD
    J Lipid Res; 1981 Aug; 22(6):990-7. PubMed ID: 7276756
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mode of action of terbufibrol (INN) a hypolipidemic agent on rat liver sterol synthesis.
    Löser R; Schliack M; Moreth W
    Artery; 1982; 10(3):180-92. PubMed ID: 7201785
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Importance of mevalonate-derived products in the control of HMG-CoA reductase activity and growth of human lung adenocarcinoma cell line A549.
    Bennis F; Favre G; Le Gaillard F; Soula G
    Int J Cancer; 1993 Oct; 55(4):640-5. PubMed ID: 8406993
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vivo formation of 25-hydroxycholesterol from endogenous cholesterol after a single meal, dietary cholesterol challenge.
    Johnson KA; Morrow CJ; Knight GD; Scallen TJ
    J Lipid Res; 1994 Dec; 35(12):2241-53. PubMed ID: 7897321
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of ovarian cholesterol metabolism: control of 3-hydroxy-3-methylglutaryl coenzyme A reductase and acyl coenzyme A:cholesterol acyltransferase.
    Schuler LA; Toaff ME; Strauss JF
    Endocrinology; 1981 Apr; 108(4):1476-86. PubMed ID: 7472277
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS; Bacon SP; Illingworth DR
    J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of HMG CoA reductase by the administration of 20,25-diazacholesterol.
    Langdon R; El-Masry S; Counsell RE
    J Lipid Res; 1977 Jan; 18(1):24-31. PubMed ID: 833506
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alteration of cholesterol synthesis in rat liver as induced by 4-methyl-5-hydroxy valeric acid.
    Díaz-Zagoya JC; Hurtado ME; González J
    Experientia; 1976 Sep; 32(9):1138-40. PubMed ID: 971744
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Delivery of mevalonate to murine extrahepatic tissues via mini-osmotic pumps.
    Duncan RE; El-Sohemy A; Archer MC
    J Pharmacol Toxicol Methods; 2004; 50(2):139-43. PubMed ID: 15385088
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatic cholesterol metabolism in obesity: activity of microsomal 3-hydroxy-3-methylglutaryl coenzyme A reductase.
    Angelin B; Backman L; Einarsson K; Eriksson L; Ewerth S
    J Lipid Res; 1982 Jul; 23(5):770-3. PubMed ID: 7119574
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circadian rhythm of HMG-CoA reductase and insulin in African green monkeys.
    Hulcher FH; Reynolds J; Rose JC
    Biochem Int; 1985 Feb; 10(2):177-85. PubMed ID: 3888223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.